PUBLICATIONS

 

• Wright N, Rida PCG, Aneja R. Tackling intra- and inter- tumor heterogeneity to combat triple negative breast cancer. Front Biosci (Landmark Ed). In Press.
   

• Rakha EA, Agarwal D, Green AR, Ashankyty I, Ellis IO, Ball G, Alaskandarany MA. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer. Histopathology. 2017 Mar. 70(4):622-631. doi: 10.1111/his.13108. Epub 2016 Dec 28. PubMed PMID: 27782306: online 
   

• Sonbul SN, Gorringe KL, Aleskandarany MA, Mukherjee A, Green AR, Ellis IO, Rakha EA. Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma. J Pathol Clin Res. 2017 Mar 30. 3(2):105-114. doi: 10.1002/cjp2.65. eCollection 2017 Apr. PubMed PMID: 28451459: online - download

 

• Miligy I, Mohan P, Gaber A, Aleskandarany MA, Nolan CC, Diez-Rodriguez M, Mukherjee A, Chapman C, Ellis IO, Green AR, Rakha EA. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Histopathology. 2017 Mar 22. doi: 10.1111/his.13217. [Epub ahead of print] PubMed PMID: 28326600: online 
   

• Mittal K, Choi da H, Ogden A, Donthamsetty S, Melton B, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EAM, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R. Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells. Sci Rep. 2017 Mar 8: online - download

 

• Ogden A, Garlapati C, Li X, Turaga R, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt C, Krishnamurti U, Reid M, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida PC, Aneja R. Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer. Sci Rep. 2017 Feb 20: online - download

 

• Rakha EA, Green AR. Molecular classification of breast cancer: what the pathologist needs to know. Pathology. 2017 Feb. 49(2):111-119. doi: 10.1016/j.pathol.2016.10.012. Epub 2016 Dec 28. PubMed PMID: 28040199: online

 

• Wright N, Xia J, Cantuaria G, Klimov S, Jones M, Neema P, Il'yasova D, Krishnamurti U, Li X, Reid MD, Gupta M, Rida PC, Osan R, Aneja R. Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations. PLoS One. 2017 Jan 13. 12(1):e0170095 PMID: 28085947: online - download

 

• Wright N, Rida P, Krishnamurti U, Li X, Aneja R. Targeted drugs and diagnostic assays: Companions in the race to combat ethnic disparity. Front Biosci (Landmark Ed). 2017 Jan 1. PMID: 27814611: online - download

 

• Li X, Wetherilt CS, Krishnamurti U, Yang J, Ma Y, Styblo TM, Meisel JL, Peng L, Siddiqui MT, Cohen C, Aneja R. Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer. Am J Clin Pathol. 2016 Oct 14. 6(4):496-502. PMID: 27686176: online - download

 

• Alshareeda AT, Negm OH, Aleskandarany MA, Green AR, Nolan C, TigHhe PJ, Madhusudan S, Ellis IO, Rakha EA. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein. Breast Cancer Res Treat. 2016 Aug. 159(1):41-53. doi: 10.1007/s10549-016-3915-8. Epub 2016 Jul 27. PubMed PMID: 27464795: online 
   

• Li XB, Krishnamurti U, Bhattarai S, Klimov S, Reid MD, O'Regan R, Aneja R. Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Am J Clin Pathol. 2016 Jun 14. 5 (6):871-8. PMID: 27298399: online - download

 

• Alshareeda AT, Negm OH, Green AR, Nolan CC, Tighe P, Albarakati N, Sultana R, Madhusudan S, Ellis IO, Rakha EA. KPNA2 is a nuclear export protein that contributes to aberrantlocalisation of key proteins and poor prognosis of breast cancer. Br J Cancer. 2015 Jun 9. 112(12):1929-37. doi: 10.1038/bjc.2015.165. Epub 2015 May 19. PubMed PMID: 25989275: online - download
   

• Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, Bowen N, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R. Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers. Oncotarget. 2015 Apr 30. 6(12):10487-97: online - download

 

• Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Oncotarget. 2015 Mar 20. 6(8):6076-91. PMID: 25788277: online - download
   

• Al-Kaabi MM, Alshareeda AT, Jerjees DA, Muftah AA, Green AR, Alsubhi NH, Nolan CC, Chan S, Cornford E, Madhusudan S, Ellis IO, Rakha EA. Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response. Br J Cancer. 2015 Mar 3. 112(5):901-11. doi: 10.1038/bjc.2014.576. Epub 2015 Feb 17. PubMed PMID: 25688741: online - download
   

• Green AR, Caracappa D, Benhasouna AA, Alshareeda A, Nolan CC, Macmillan RD, Madhusudan S, Ellis IO, Rakha EA. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015 Jan. 149(2):353-62. doi: 10.1007/s10549-014-3230-1. Epub 2014 Dec 21. PubMed PMID: 25528020: online - download